— Know what they know.
Not Investment Advice

EOSS OTC

EOS, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Consumer Defensive · Household & Personal Products · Tech Score Neutral · Power 50 · $60478 mcap · 213M float · 0.029% daily turnover

Balance Sheet Trends

Total Assets
$497K -9.0% ▼
5Y CAGR: -23.8%
Total Liabilities
$2M +6.7% ▲
5Y CAGR: +39.2%
Shareholders Equity
-$1M -16.8% ▼
Cash & Investments
$14K -21.3% ▼
5Y CAGR: -16.9%
Total Debt
$123K -60.9% ▼
Net Debt
$108K -63.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$296K$122K$24K$18K$14K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$296K$122K$24K$18K$14K
Net Receivables$2M$1M$548K$160K$225K
Inventory$11K$215K$30K$46K$79K
Other Current Assets$317K$1M$1M$173K$4K
Total Current Assets$3M$3M$2M$426K$487K
Property, Plant & Equip.$43K$8K$92K$121K$10K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$21K$0$0$0$0
Other Non-Current Assets$128K$1M$0$0$0
Total Non-Current Assets$191K$1M$92K$121K$10K
Total Assets$3M$2M$2M$546K$497K
— Liabilities —
Accounts Payable$2K$18K$0$0$10K
Short-Term Debt$23K$44K$80K$68K$53K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$99K$384K$619K$1M$1M
Total Current Liabilities$222K$529K$792K$1M$1M
Long-Term Debt$0$123K$204K$116K$65K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$12K$124K$252K$197K$67K
Total Liabilities$233K$731K$1M$1M$2M
— Equity —
Common Stock$74K$74$180K$184K$605K
Retained Earnings$3M$2M$723K-$1M-$2M
Accumulated OCI$13K$112K$133K$43K-$2K
Total Stockholders Equity$3M$2M$1M-$911K-$1M
Total Liabilities & Equity$3M$2M$2M$546K$497K
— Key Metrics —
Total Debt$35K$169K$370K$313K$123K
Net Debt-$261K$45K$345K$295K$108K
Total Investments$21K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms